Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Clinical Laboratory Achieves CLIA Certification

NEW YORK (GenomeWeb News) – Korean genomics services firm Macrogen said today that its Rockville, Md.-based subsidiary has received CLIA certification.

Macrogen Clinical Laboratory, launched in late 2012, offers diagnostic testing for genetic diseases through clinical whole-exome sequencing and targeted sequencing, and provides a "total genomic solution" for the clinical and research area, its Medical Director Sechin Cho said in a statement. He added that the company will expand its services to include DNA chip-based neo-genome scanning and cancer diagnostic panels, as well as transcriptome sequencing.

Macrogen is based in Seoul, South Korea and is equipped with 30 next-generation sequencers from Illumina, Roche, and Life Technologies' Ion Proton business, it said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.